PubRank
Search
About
Omar A Minai
Author PubWeight™ 33.21
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Causes and circumstances of death in pulmonary arterial hypertension.
Am J Respir Crit Care Med
2013
2.64
2
Comorbidities in chronic obstructive pulmonary disease.
Proc Am Thorac Soc
2008
2.20
3
Safety of diagnostic bronchoscopy in patients with pulmonary hypertension.
Respiration
2009
1.45
4
Cardiac disease in chronic obstructive pulmonary disease.
Proc Am Thorac Soc
2008
1.21
5
Pulmonary nodules in lung transplant recipients: etiology and outcome.
Chest
2004
1.19
6
Sleep abnormalities and treatment in emphysema.
Proc Am Thorac Soc
2008
1.03
7
Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery.
Respir Med
2010
1.01
8
Lung transplantation for idiopathic pulmonary fibrosis.
Ann Thorac Surg
2007
1.00
9
Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.
Proc Am Thorac Soc
2008
0.99
10
Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema.
Am J Respir Crit Care Med
2007
0.97
11
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.
Respir Med
2011
0.96
12
Sleep quality, depression, and quality of life in patients with pulmonary hypertension.
Lung
2010
0.96
13
Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients.
J Heart Lung Transplant
2007
0.96
14
Long-term continuous positive airway pressure therapy normalizes high exhaled nitric oxide levels in obstructive sleep apnea.
J Clin Sleep Med
2013
0.94
15
Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving ≥5 years after baseline right-sided cardiac catheterization.
Am J Cardiol
2012
0.90
16
Presence and outcomes of kidney disease in patients with pulmonary hypertension.
Clin J Am Soc Nephrol
2014
0.90
17
BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
Am J Med Genet A
2008
0.89
18
Auto-positive end-expiratory pressure: mechanisms and treatment.
Cleve Clin J Med
2005
0.87
19
Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.
Respir Med
2008
0.87
20
Abnormal platelet aggregation in idiopathic pulmonary arterial hypertension: role of nitric oxide.
Am J Physiol Lung Cell Mol Physiol
2012
0.85
21
Lung transplantation in a patient with Mounier-Kuhn syndrome.
J Thorac Cardiovasc Surg
2006
0.84
22
Inflammatory myofibroblastic tumor of the lung: recurrence after steroid treatment.
J Thorac Imaging
2008
0.82
23
Overview of the perioperative management of lung volume reduction surgery patients.
Proc Am Thorac Soc
2008
0.81
24
The role of self-expandable metallic stents for the treatment of airway complications after lung transplantation.
Transplantation
2003
0.80
25
The evaluation and preparation of the patient for lung volume reduction surgery.
Proc Am Thorac Soc
2008
0.80
26
Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.
Clin Transl Sci
2013
0.80
27
Electrocardiography at diagnosis and close to the time of death in pulmonary arterial hypertension.
Ann Noninvasive Electrocardiol
2013
0.79
28
Bosentan in systemic sclerosis.
Drugs Today (Barc)
2008
0.78
29
A young man with unexplained dyspnea.
Cleve Clin J Med
2006
0.77
30
Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy.
Respir Med
2007
0.77
31
Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of lung transplants.
Chest
2003
0.76
32
Impaired functional capacity predicts mortality in patients with obstructive sleep apnea.
Ann Am Thorac Soc
2014
0.75
33
Race as an independent prognostic factor in patients with idiopathic pulmonary arterial hypertension.
Am J Cardiol
2005
0.75
34
Pulmonary hypertension before first and second lung transplantation.
Clin Transplant
2012
0.75
35
Referral for lung transplantation: a moving target.
Chest
2005
0.75
36
What risks does a history of pulmonary hypertension present for patients undergoing noncardiac surgery?
Cleve Clin J Med
2007
0.75
37
Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension.
Am J Cardiol
2012
0.75
38
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension.
Cleve Clin J Med
2003
0.75
39
Lung or Heart-Lung Transplant in Pulmonary Arterial Hypertension: What Is the Impact of Systemic Sclerosis?
Exp Clin Transplant
2017
0.75
40
Reprocessing the bronchoscope: the challenges.
Semin Respir Crit Care Med
2004
0.75
41
Prevalence and significance of decreased bone density in pulmonary arterial hypertension.
South Med J
2012
0.75
42
Acanthosis nigricans following single lung transplantation: a case report.
Prog Transplant
2006
0.75
43
A 45-year-old woman with systemic lupus erythematosus and progressive dyspnea.
Chest
2007
0.75
44
Implementing a shared-care approach to improve the management of patients with pulmonary arterial hypertension.
Cleve Clin J Med
2003
0.75
45
Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
Drugs Today (Barc)
2004
0.75